Larvol Delta - Action-Mechanisms-and-Scientific-Rationale-of-Using-Nasal-Vaccine-HeberNasvac-for-the-Treatment-of-Chronic-Hepatitis-B

HeberNasvac (ABX203) - Center for Genetic Engineering and Biotechnology, Abivax

http://www.ncbi.nlm.nih.gov/pubmed/36560498

Dec 24, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next